🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial evaluates whether early switching from modified fluorou...
Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Start Date
2021-05-27
Trial ID
NCT04539808
Abbreviated Title: Neoadjuvant FOLFIRINOX combined with Pembrolizumab follo...
Status
Recruiting
Location
Baylor College of Medicine
Start Date
2022-08-31
Trial ID
NCT05132504
Treatments Being Tested
Pancreatic cancer exhibits significant heterogeneity, which poses a major c...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05
Trial ID
NCT07592819
Treatments Being Tested
Surgical resection is the only potentially curative treatment for patients ...
Status
Terminated
Location
Smilow Cancer Hospital
Start Date
2017-06-26
Trial ID
NCT03099265
Treatments Being Tested
The prognosis of pancreatic cancer is extremely poor. Current guidelines re...
Status
Unknown
Location
The second affiliated hospital of Zhejiang University
Start Date
2018-07-01
Trial ID
NCT03633734
Treatments Being Tested
Ampullary adenocarcinoma (AAC) is a rare gastrointestinal cancer with varyi...
Status
Recruiting
Location
Fondazione Poliambulanza
Start Date
2023-07-01
Trial ID
NCT06068023
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of mFOLFIRINOX plus r...
Status
Recruiting
Location
Shanghai Cancer Center
Start Date
2024-01-10
Trial ID
NCT06149689
Treatments Being Tested
The main purpose of * To observe the overall survival of patients with res...
Status
Unknown
Location
Multiple Locations
Start Date
2021-04-01
Trial ID
NCT04835064
Treatments Being Tested
This is an open-label, phase 1/2, multiple-indication platform study to exp...
Status
Active Not Recruiting
Location
Nationales Centrum für Tumorerkrankungen Heidelberg
Start Date
2021-10-27
Trial ID
NCT07280377
The purpose of this study is to evaluate the efficacy of mFOLFIRINOX plus r...
Status
Recruiting
Location
Shanghai Cancer Center
Start Date
2024-04-01
Trial ID
NCT06249321
Treatments Being Tested